|
| |
Image Results
Loading...
Loading...
Molecular Partners And Centocor Pages on BioPortfolio:
|
BioPortfolio Biotechnology and Pharmaceutical News January to ...
Molecular Partners AG collaborates with Centocor Research & Development, Inc. Protagen raises €1 million to expand its protein biochips business unit ...
http://www.bioportfolio.com/biotech_news/january_to_march_20...
|
Biotechnology and Pharmaceutical News Site Map
... Molecular Partners Secures CHF 46 million in Series B Financing Led by ...... Molecular Partners AG collaborates with Centocor Research & Development,
...
http://www.bioportfolio.com/biotech_news/site_map.htm...
|
BioPortfolio News: - Ortho Biotech Oncology Research &...
8 Dec 2009 ... Biotech Oncology Research & Development or its research partners, ... LLC, Centocor Ortho Biotech Inc., Centocor R&D, Inc. and Janssen-Cilag GmbH. ... Oral
Session: Molecular Pharmacology, Drug Resistance I Sunday, ...
http://www.bioportfolio.com/news/Ortho-Biotech-Oncology-Rese...
|
BioPortfolio - RBC Bioscience - Profile
RBC Bioscience is a total solution molecular biology product and service provider. RBC has a worldwide sales network with headquarters in Taiwan and
research partners based in ... Press Releases on RBC Bioscience: Centocor Ortho
Biotech ...
http://www.bioportfolio.com/biocorporate/11368-RBC%252BBiosc...
|
Fast Track Regulatory Approval for TheraCIM h-R3, a new drug for ...
5 Mar 2002 ... The Center of Molecular Immunology received a Fast Track Regulatory Approval for ... It partners with biotechnology and pharmaceutical companies, as well as with
drug ... The first was Panorex, developed by Centocor inc. ...
http://www.bioportfolio.com/news/btech_030802_1.htm...
| Results from other life science and pharmaceutical sites:
Molecular Partners AG Collaborates with Centocor Research And ...
15 Jan 2008 ... Zurich, Switzerland, January 15, 2008 -- Molecular Partners AG today announced a collaborative research and license agreement with Centocor ...
http://www.biospace.com/news_story.aspx?NewsEntityId=82709...
|
News: Molecular Partners Raises Almost $45M to Support Phase II ...
15 Dec 2009 ... Company has alliances with Centocor, Roche, and Bayer Schering Pharma. ... Germany-based Molecular Partners raised CHF 46 million (about ...
http://www.genengnews.com/news/bnitem.aspx?name=71124712...
|
BioSpace - Centocor Research And Development, Inc. News, Search ...
Molecular Partners AG Reaches all Research Milestones in Collaboration with Centocor Research And Development, Inc. 5/14/2009 11:45:42 AM More. ...
http://www.biospace.com/company_profile.aspx?CompanyId=10025...
|
Gate 1 Presentation
Genentech; Hoffman-La Roche; Centocor; Abbott; MedImmune ... Molecular Partners. Switzerland, 2004. Private ... Cardinal Health, Centocor. BioWa, Aphton ...
http://www.stanford.edu/class/msande273/Aviditek-Gate%201%20...
|
Molecular Partners AG Secures CHF 46 million in Series B Financing ...
15 Dec 2009 ... Molecular Partners is collaborating with Centocor Research & Development, Inc. in the development of DARPins for two undisclosed targets. ...
http://www.biospace.com/news_story.aspx?NewsEntityId=165539...
|
MRCT Licence Rights to Develop Potential Novel Immunotherapy
27 Jan 2009 ... Centocor Ortho Biotech Inc. has exclusively licensed patents relating to ... Its work ranges from molecular level science to public health ...
http://www.jnj.com/connect/NewsArchive/product-news-archive/...
|
Epigenomics AG - english - Company - Network & Partners
Strategic Partners. 09/2007, 10/2008: Abbott Molecular. .... 12/2006: Centocor Inc., a US based biomedicines company and Epigenomics entered into an R&D ...
http://www.epigenomics.com/en/Company/NetworkPartners/...
|
Ortho Biotech Oncology Research & Development Data to Be Presented ...
4 Dec 2009 ... Oral Session: Molecular Pharmacology, Drug Resistance I ... by Ortho Biotech Oncology Research & Development or its research partners, ... LLC, Centocor
Ortho Biotech Inc., Centocor R&D, Inc. and Janssen-Cilag GmbH. ...
http://www.jnj.com/connect/news/all/20091204_090000...
|
Chromos Molecular Systems Inc. Shareholders Approve Acquisition Of ...
24 /PRNewswire-FirstCall/ - Chromos Molecular Systems Inc. , today announced ... corporate partnerships with partners including Pfizer Inc., Centocor, Inc., ...
http://www.biospace.com/news_story.aspx?NewsEntityId=3504...
|
Crucell: R&D Partners & Licensees
3 Nov 2009 ... Centocor Inc. Jan 2009. STAR®. Monoclonal antibodies. CSL Ltd. Dec. 2008 .... Molecular Medicine BioServices, Inc. Dec. 2001. PER.C6® ...
http://www.crucell.com/Partners%20-%20General%20Overview...
|
|
